Advertisement
U.S. markets open in 2 hours 50 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
411.38+3.69 (+0.91%)
At close: 04:00PM EDT
413.90 +2.52 (+0.61%)
Pre-Market: 04:11AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close407.69
Open409.24
Bid414.55 x 1100
Ask414.98 x 1200
Day's Range409.24 - 415.50
52 Week Range297.75 - 448.40
Volume926,245
Avg. Volume1,310,963
Market Cap106.263B
Beta (5Y Monthly)0.35
PE Ratio (TTM)29.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
63% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VRTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vertex Pharmaceuticals Incorpor
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 4,800 employees. It has research programs and facilities in the U.S., the UK, and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more